Suppr超能文献

相似文献

1
Antifungal susceptibility profile of human-pathogenic species of Lichtheimia.
Antimicrob Agents Chemother. 2010 Jul;54(7):3058-60. doi: 10.1128/AAC.01270-09. Epub 2010 Apr 26.
2
In vitro activity of antifungals against Zygomycetes.
Clin Microbiol Infect. 2009 Oct;15 Suppl 5:71-6. doi: 10.1111/j.1469-0691.2009.02984.x.
3
In Vitro Activity of Isavuconazole and Comparators against Clinical Isolates of the Mucorales Order.
Antimicrob Agents Chemother. 2015 Dec;59(12):7735-42. doi: 10.1128/AAC.01919-15. Epub 2015 Oct 5.
5
Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers.
Antimicrob Agents Chemother. 2009 Apr;53(4):1686-9. doi: 10.1128/AAC.01467-08. Epub 2009 Jan 26.

引用本文的文献

1
A rare intestinal mucormycosis caused by in a patient with diabetes: a case report.
Front Med (Lausanne). 2024 Oct 16;11:1435239. doi: 10.3389/fmed.2024.1435239. eCollection 2024.
2
The First Case of Pulmonary Mucormycosis Caused by .
Ann Lab Med. 2024 Jul 1;44(4):371-374. doi: 10.3343/alm.2023.0426. Epub 2024 Mar 13.
3
Mass spectrometry-based proteomics as an emerging tool in clinical laboratories.
Clin Proteomics. 2023 Aug 26;20(1):32. doi: 10.1186/s12014-023-09424-x.
4
Necrotizing fasciitis in neonate by : A case study.
Access Microbiol. 2022 Mar 9;4(3):000327. doi: 10.1099/acmi.0.000327. eCollection 2022.
5
Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis.
J Fungi (Basel). 2022 Apr 25;8(5):445. doi: 10.3390/jof8050445.
6
Hepatic failure and malnutrition as predisposing factors of cutaneous mucormycosis in a pediatric patient.
Med Mycol Case Rep. 2021 Dec 31;35:26-29. doi: 10.1016/j.mmcr.2021.12.005. eCollection 2022 Mar.
9
Direct Visualization of Fungal Burden in Filamentous Fungus-Infected Silkworms.
J Fungi (Basel). 2021 Feb 13;7(2):136. doi: 10.3390/jof7020136.
10
The impact of episporic modification of on virulence and interaction with phagocytes.
Comput Struct Biotechnol J. 2021 Jan 20;19:880-896. doi: 10.1016/j.csbj.2021.01.023. eCollection 2021.

本文引用的文献

1
Species recognition and clinical relevance of the zygomycetous genus Lichtheimia (syn. Absidia pro parte, Mycocladus).
J Clin Microbiol. 2010 Jun;48(6):2154-70. doi: 10.1128/JCM.01744-09. Epub 2010 Mar 31.
2
Spectrum of zygomycete species identified in clinically significant specimens in the United States.
J Clin Microbiol. 2009 Jun;47(6):1650-6. doi: 10.1128/JCM.00036-09. Epub 2009 Apr 22.
3
Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers.
Antimicrob Agents Chemother. 2009 Apr;53(4):1686-9. doi: 10.1128/AAC.01467-08. Epub 2009 Jan 26.
6
Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases.
Clin Infect Dis. 2006 Apr 1;42(7):e61-5. doi: 10.1086/500212. Epub 2006 Feb 21.
7
Posaconazole as salvage therapy for zygomycosis.
Antimicrob Agents Chemother. 2006 Jan;50(1):126-33. doi: 10.1128/AAC.50.1.126-133.2006.
8
Epidemiology and outcome of zygomycosis: a review of 929 reported cases.
Clin Infect Dis. 2005 Sep 1;41(5):634-53. doi: 10.1086/432579. Epub 2005 Jul 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验